XRCC1 and acute myeloid leukemia: Also, the XRCC1 polymorphisms have been extensively studied in relation to acute myeloid leukemia (AML) [3, 13, 15, 16], acute lymphoblastic leukemia [17–19], chronic lymphocytic leukemia [20, 21], and lymphoma [22–26].